Literature DB >> 11878827

Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.

Sergiu T Leu1, Suchitra Batni, Monte J Radeke, Lincoln V Johnson, Don H Anderson, Dennis O Clegg.   

Abstract

Drusen are abnormal extracellular matrix deposits characteristic of age-related macular degeneration (AMD), a leading cause of blindness in the aging human population. The mechanisms underlying drusen formation are not well characterized. The purpose of this study was to examine the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in drusen, and in the surrounding cells and tissue. To assess the extent of MMP and TIMP expression by retinal pigment epithelial (RPE) cells, cDNA arrays were screened with probes generated from cultured human RPE cells. The distribution of MMP-1, -2 and -3 and TIMP-1, -2, -3 and -4 was determined using immunohistochemistry in human RPE choroid from donor eyes with and without a clinical history of AMD. Gelatinase activity was assessed in unfixed frozen sections using in situ zymography. In cultured RPE cells, expression of 10 MMP and all four known TIMP mRNAs was detected. MMP immunoreactivity was widespread in the RPE choroid, but was absent from the interior of drusen. TIMP-3, but not other TIMPs, was detected in the drusen interior. Likewise, metal ion dependent gelatinase activity could be detected in RPE choroid, but not in drusen. These results show that, while metalloproteinase activity is widespread throughout the RPE choroid, drusen are cold spots for proteolysis. The data lead to the speculation that high TIMP-3 concentrations within drusen could inhibit MMPs and as a result slow the proteolytic degradation of these deposits. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11878827     DOI: 10.1006/exer.2001.1112

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  22 in total

1.  Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.

Authors:  Chrysanthos Symeonidis; Eudoxia Diza; Eleni Papakonstantinou; Efimia Souliou; George Karakiulakis; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

2.  The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas.

Authors:  Yuko Yamada; Kazuko Ishibashi; Kazuki Ishibashi; Imran A Bhutto; Jane Tian; Gerard A Lutty; James T Handa
Journal:  Exp Eye Res       Date:  2005-12-20       Impact factor: 3.467

3.  Retinal pigment epithelium transcriptome analysis in chronic smoking reveals a suppressed innate immune response and activation of differentiation pathways.

Authors:  Lei Wang; Koray D Kaya; Sujung Kim; Matthew J Brooks; Jie Wang; Ying Xin; Jiang Qian; Anand Swaroop; James T Handa
Journal:  Free Radic Biol Med       Date:  2020-07-04       Impact factor: 7.376

4.  Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental system.

Authors:  Masashi Fujihara; Marisol Cano; James T Handa
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-14       Impact factor: 4.799

5.  Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response.

Authors:  Jane Tian; Kazuki Ishibashi; Kazuko Ishibashi; Karen Reiser; Rhonda Grebe; Shyam Biswal; Peter Gehlbach; James T Handa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

Review 6.  Minireview: Fibronectin in retinal disease.

Authors:  Charles G Miller; Greg Budoff; Jonathan L Prenner; Jean E Schwarzbauer
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-20

7.  Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2.

Authors:  Sharon Elliot; Paola Catanuto; William Stetler-Stevenson; Scott W Cousins
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

8.  Expression of MMP-2 and MMP-9 in retinoblastoma and their significance.

Authors:  Hua Long; Bo Zhou; Fa-Gang Jiang
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

Review 9.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

Review 10.  The choroid as a sclera growth regulator.

Authors:  Jody A Summers
Journal:  Exp Eye Res       Date:  2013-03-23       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.